Viracept (Nelfinavir Mesylate, AG1343): A Potent, Orally Bioavailable Inhibitor of HIV-1 Protease
Year: 1997
Type: article
Source: Journal of Medicinal Chemistry
DOI: 10.1021/jm9704098
Authors: Stephen W. Kaldor, Vincent J. Kalish, Jay F. Davies, Bhasker V. Shetty, James E. Fritz, Krzysztof Appelt, Jeffrey A. Burgess, Kristina M. Campanale, Nickolay Y. Chirgadze, David K. Clawson, Bruce A. Dressman, Steven D. Hatch, Deborah A. Khalil, Maha B. Kosa, Penny P. Lubbehusen, Mark A. Muesing, Amy K. Patick, Siegfried H. Reich, Kenneth S. Su, John H. Tatlock
Institution: Eli Lilly (United States)
Language: English
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2027095884